Skip to main content
Log in

Effect of prostaglandin E2 and 3-morpholinosydnonimine (SIN-1) on arachidonic acid metabolism in fMLP-stimulated rat neutrophils and on thrombin-induced human platelet aggregation

  • Inflammation and Immunomodulation
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

The effects of prostaglandin (PG) E2 and the nitric oxide (NO) donor SIN-1 on leukotriene (LT) release from formyl-methionyl-leucyl-phenylalanine (fMLP) (100 nM)-stimulated rat peritoneal neutrophils (RPN) and on thrombin-induced aggregation of washed human platelets were investigated. Both PGE2 (1–100 nM) and SIN-1 (30–300 μM) inhibited release of LTB4 and cysteinyl-LT from RPN in a concentration-dependent manner. The combined effects of PGE2 and SIN-1 were not greater than expected by summation. On the other hand, the inhibitory effect of SIN-1 (0.5 or 1.0 μM) on platelet aggregation was potentiated by PGE2 (0.3–5 μM) in a concentration-dependent manner, while PGE2 alone in the concentrations used had only marginal effects. The results suggest differential regulation of platelet and leukocyte functions by the mediators PGE2 and NO, which could be relevant for various physiological and pathophysiological conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. L. Jørgensen, M. A. Packham, H. C. Rowsell and J. F. Mustard,Deposition of formed elements of blood on the intima and signs of intimal injury in the aorta of rabbit, pig, and man. Lab. Invest.27, 341–350 (1972).

    PubMed  Google Scholar 

  2. J. Maclouf, R. C. Murphy and P. M. Henson,Platelets and endothelial cells contribute to the production of LTC 4 by transcellular metabolism with neutrophils. InAdvances in Prostaglandin, Thromboxane, and Leukotriene Research, vol. 19. (Eds. B. Samuelsson, P.Y.-K. Wong and F.F. Sun) pp. 259–262, Raven Press, New York 1989.

    Google Scholar 

  3. A. Boogaerts, O. Yamada, H. S. Jacob and C. F. Moldow,Enhancement of granulocyte-endothelial cell adherence and granulocyte-induced cytotoxicity by platelet release products. Proc. Natl. Acad. Sci. USA79, 7019–7023 (1982).

    PubMed  Google Scholar 

  4. S. Moncada, R. J. Gryglewski, S. Bunting and J. R. Vane,An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature263, 663–665 (1976).

    PubMed  Google Scholar 

  5. R. F. Furchgott and J. V. Zawadzki,The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature288, 373–376 (1980).

    PubMed  Google Scholar 

  6. R. M. J. Palmer, A. G. Ferrige and S. Moncada,Nitric oxide release accounts for the biological activity of endothelium derived relaxing factor. Nature327, 524–526 (1987).

    PubMed  Google Scholar 

  7. P. R. Myers, R. L. Minor Jr., R. Guerra Jr., J. N. Bates and D. G. Harrison,Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature345, 161–163 (1990).

    PubMed  Google Scholar 

  8. M. W. Radomski, R. M. J. Palmer and S. Moncada,The anti-aggregating properties of vascular endothelium: Interactions between prostacylin and nitric oxide. Br. J. Pharmacol.92, 639–646 (1987).

    PubMed  Google Scholar 

  9. P. Ney, H. Schröder and K. Schrör,Nitrovasodilator-induced inhibition of LTB 4 release from human PMN may be mediated by cyclic GMP. Eicosanoids3, 243–245 (1990).

    PubMed  Google Scholar 

  10. S. Bourgoin, P. Poubelle and P. Borgeat,Effet du SIN-1 sur la synthèse de leukotriènes dans les polymorphonucléaires humains. Path. Biol.35, 238–240 (1987).

    Google Scholar 

  11. P. S. Lidbury, E. Antunes, G. de Nucci and J. R. Vane,Interactions of iloprost and sodium nitroprusside on vascular smooth muscle and platelet aggregation. Br. J. Pharmacol.98, 1275–1280 (1989).

    PubMed  Google Scholar 

  12. H. Sinzinger, P. Fitscha, J. O'Grady, F. Rauscha, W. Rogatti and J. R. Vane,Synergistic effect of prostaglandin E 1 and isosorbide dinitrate in peripheral vascular disease. Lanceti, 627–628 (1990).

    Google Scholar 

  13. W. Bothwell, M. Verburg, M. Wynalda, E. G. Daniels and F. A. Fitzpatrick,A radioimmunoassay for the unstable pulmonary metabolites of prostaglandin E 1 and E 2:An indirect index of their in vivo disposition and pharmacokinetics. J. Pharmacol. Exp. Ther.220, 229–235 (1982).

    PubMed  Google Scholar 

  14. G. A. Higgs and J. A. Salmon,Cyclo-oxygenase products in carrageenin-induced inflammation. Prostaglandins17, 737–746 (1979).

    Google Scholar 

  15. E. A. Ham, D. D. Soderman, M. E. Zanetti, H. W. Dougherty, E. McCauley and F. A. Kuehl Jr.,Inhibition by prostaglandins of leukotriene B 4 release from activated neutrophils. Proc. Natl. Acad. Sci. USA80, 4349–4353 (1983).

    PubMed  Google Scholar 

  16. A. Szczeklik, R. J. Gryglewski, M. Wandzilak, M. Grzywacz, J. Radwan and J. Musial,Effects of prostanoids on generation of superoxide ions by human neutrophils. InProstaglandins in Clinical Research. (Eds. H. Sinzinger and K. Schrör) pp. 215–219, Alan R. Liss, New York 1987.

    Google Scholar 

  17. K. Schrör and G. Hecker,Different effects of E- and I-type prostaglandins on human platelet and polymorphonuclear cell function. InProstaglandin E 1 in Atherosclerosis. (Eds. H. Sinzinger and W. Rogatti) pp. 22–31, Springer, Heidelberg 1986.

    Google Scholar 

  18. J. Reden,Molsidomine. Blood Vessels27, 282–294 (1990).

    PubMed  Google Scholar 

  19. R. M. J. Palmer, R. J. Stepney, G. A. Higgs and K. E. Eakins,Chemokinetic activity of arachidonic acid lipoxygenase products on leucocytes of different species. Prostaglandins20, 411–418 (1980).

    PubMed  Google Scholar 

  20. K. W. Dreyling, U. Hoppe, B. A. Peskar, K. Morgenroth, W. Kozuschek and B. M. Peskar,Leukotriene synthesis by human gastrointestinal tissues. Biochim. Biophys. Acta878, 184–193 (1986).

    PubMed  Google Scholar 

  21. M. W. Radomski and S. Moncada,An improved method for washing of human platelets with prostacyclin. Thromb. Res.30, 383–389 (1983).

    PubMed  Google Scholar 

  22. J. M. Gerrard, J. D. Peller, T. P. Krick and J. G. White,Cyclic AMP and platelet prostaglandin synthesis. Prostaglandins14, 39–50 (1977).

    PubMed  Google Scholar 

  23. I. Matsuoka, N. Nakahata and H. Nakanishi,Inhibitory effect of 8-bromo cyclic GMP on an extracellular Ca 2+-dependent arachidonic acid liberation in collagen-stimulated rabbit platelets. Biochem. Pharmacol.38, 1841–1847 (1989).

    PubMed  Google Scholar 

  24. R. I. Levin, B. B. Weksler and E. A. Jaffe,The interaction of sodium nitroprusside with human endothelial cells and platelets: nitroprusside and prostacyclin synergistically inhibit platelet function. Circulation66, 1299–1307 (1982).

    PubMed  Google Scholar 

  25. D. H. Maurice and R. J. Haslam,Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: Inhibition of cyclic AMP breakdown by cyclic GMP. Mol. Pharmacol.37, 671–681 (1990).

    PubMed  Google Scholar 

  26. S. J. Gray and S Heptinstall,Interactions between prostaglandin E 2 and inhibitors of platelet aggregation which act through cyclic AMP. Eur. J. Pharmacol.194, 63–70 (1991).

    PubMed  Google Scholar 

  27. M. E. Gerritsen and C. D. Cheli,Arachidonic acid and prostaglandin endoperoxide metabolism in isolated rabbit coronary microvessels and isolated and cultivated coronary microvessel endothelial cells. J. Clin. Invest.72, 1658–1671 (1983).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pallapies, D., Jirmann, K.U., Rademann, J. et al. Effect of prostaglandin E2 and 3-morpholinosydnonimine (SIN-1) on arachidonic acid metabolism in fMLP-stimulated rat neutrophils and on thrombin-induced human platelet aggregation. Agents and Actions 36, 77–82 (1992). https://doi.org/10.1007/BF01991232

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01991232

Keywords

Navigation